NDC-11 (Package) | NDC-9 (Product) | Generic Name | Brand Name (Descending) | Strength | SEER*Rx Category | Major Class | Minor Class | Administration Route | Package Effective Date | Package Discontinuation Date | Status |
---|---|---|---|---|---|---|---|---|---|---|---|
00187-0901-01 | 00187-0901 | Methyltestosterone | Testred | 10.0 mg/1 | Hormonal Therapy | Androgen | Oral | Dec. 3, 1973 | April 30, 2018 | No Longer Used | |
57377-0060-01 | 57377-0060 | Testosterone, USP and Anastrozole | Testozole | 4.0 mg/1, 60.0 mg/1 | Hormonal Therapy | Androgen/Aromatase Inhibitor | Subcutaneous | Jan. 1, 2021 | In Use | ||
00143-9750-01 | 00143-9750 | Testosterone Enanthate | Testosterone Enanthate | 200.0 mg/mL | Hormonal Therapy | Androgen | Intramuscular | Sept. 18, 2012 | In Use | ||
00574-0821-05 | 00574-0821 | Testosterone Enanthate | Testosterone Enanthate | Hormonal Therapy | Androgen | Aug. 2, 2007 | Sept. 30, 2011 | No Longer Used | |||
00591-3221-26 | 00591-3221 | Testosterone Enanthate | Testosterone Enanthate | 200.0 mg/mL | Hormonal Therapy | Androgen | Intramuscular | May 4, 2011 | Dec. 31, 2019 | No Longer Used | |
53964-0001-00 | 53964-0001 | Thiotepa | Tepadina | 15.0 mg/1 | Chemotherapy | Alkylating Agent | Nitrogen Mustard /Ethylenimine | Intracavitary, Intravenous, Intravesical | Jan. 26, 2017 | April 18, 2017 | In Use |
53964-0001-01 | 53964-0001 | Thiotepa | Tepadina | 15.0 mg/1 | Chemotherapy | Alkylating Agent | Nitrogen Mustard /Ethylenimine | Intracavitary, Intravenous, Intravesical | Jan. 26, 2017 | Aug. 1, 2018 | In Use |
53964-0002-01 | 53964-0002 | Thiotepa | Tepadina | 100.0 mg/1 | Chemotherapy | Alkylating Agent | Nitrogen Mustard /Ethylenimine | Intracavitary, Intravenous, Intravesical | Jan. 26, 2017 | March 2, 2017 | In Use |
53964-0002-02 | 53964-0002 | Thiotepa | Tepadina | 100.0 mg/1 | Chemotherapy | Alkylating Agent | Nitrogen Mustard /Ethylenimine | Intracavitary, Intravenous, Intravesical | Jan. 26, 2017 | Aug. 1, 2018 | In Use |
70121-1631-01 | 70121-1631 | Thiotepa | Tepadina | 100.0 mg/1 | Chemotherapy | Alkylating Agent | Nitrogen Mustard /Ethylenimine | Intracavitary, Intravenous, Intravesical | Aug. 15, 2017 | In Use |
Found 10,000 results in 3 milliseconds — Export these results